Abstract
A low response to ovarian stimulation in in vitro fertilization poses a unique therapeutic challenge. Gonadotropin-releasing hormone agonists (GnRHa) have been suggested as a modality for treatment of this condition. In this study, we analyzed the results of 880 in vitro fertilization treatment cycles with respect to modality of ovarian stimulation, degree of hormonal response, and number of oocytes retrieved. In patients with estradiol (E 2 )levels less than 501 pg/ml on the day of human chorionic gonadotropin administration, 27% pregnancy rate was achieved with clomiphene citrate (CC) combined with human menopausal gonadotropin (hMG), compared to 15.1% (P <0.005) with hMG alone and 20.8% (NS) with GnRHa and hMG. Pregnancy rates were not lower in these patients compared to patients with higher estradiol levels in the different stimulation protocols, but pregnancy rates were significantly lower in cycles during which three or fewer oocytes were retrieved, compared to those in which four or more oocytes were retrieved (10.8 vs 23.8%; P <0.0005). In low-retrieval cycles pregnancy rates actually decreased with increasing levels of estradiol. Our results indicate that the number of oocytes retrieved is a better prognostic parameter than E 2 levels in predicting the outcome of in vitro fertilization treatment and that GnRHa in the long protocol do not seem to be superior to CC combined with hMG for the treatment of poor responders.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Trounson AD, Leeton JF, Wood C, Webb J, Wood J: Pregnancies in human by in vitro fertilization and embryo transfer in controlled ovulatory cycles. Science 1981;212:681–682
Crosignani PG, Ragni G, Lombroso GC, Scarduelli C, de Lauretis L, Caccamo A, Dalapra L, Cavion V, Cristiani C, Wyssling H, Olivares MD: IVF: Induction of ovulation in poor responders. J Steroid Biochem 1989;32:171–173
Jones HW, Jr., Acosta A, Andrews MC, Garcia JE, Jones GS, Mantzavinos T, McDowll J, Sandow B, Veeck L, Whibley T, Wilkes C, Wright G: The importance of the follicular phase to success and failure in in vitro fertilization. Fertil Steril 1983;40:317–321
Muasher SJ: Stimulation protocols for patients with “atypical response.” In vitro fertilization and other assisted reproduction. NY Acad Sci 1988;541:82–95
Van Rysselberge M, Puissant F, Barlow P, Lejeune B, Delvigne A, Leroy F: Fertility prognosis in IVF treatment of patients with cancelled cycles. Hum Reprod 1989;4:663–666
Tanbo T, Abyholm T, Bjoro T, Dale PO: Ovarian stimulation in previous failures from in-vitro fertilization: Distinction of two groups of poor responders. Hum Reprod 1990;5:811–815
Belaisch-Allart J, Testart J, Frydman R: Utilization of GnRH agonists for poor responders in an IVF programme. Hum Reprod 1989;4:33–34
Owen EJ, Davies MC, Kingsland CR, Jacobs HS, Mason BA: The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menapausal gonadotrophin in assisted conception cycles. Hum Reprod 1989;4:749–753
Howles CM, MacNamee MC, Edwards RG: Short term use of LHRH agonist to treat poor responders entering in vitro fertilization program. Hum Reprod 1987;2:655–656
Serafin P, Stone B, Kerin J, Batzofin J, Quinn J, Marrs RD: An alternative approach to controlled ovarian hyperstimulation in “poor responders.” Pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90–95
Dor J, Ben Shlomo I, Lipitz S, Levran D, Eitchin A, Rudak E, Mashiach S: Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery. J Vitro Fert Embryo Transfer 1990;7:351–354
Dor J, Rudak E, Mashiach S, Nebel L, Serr DM, Goldman B: Periovulatory 17-beta estradiol changes and embryo morphologic features in conception and nonconceptional cycles after human in-vitro fertilization. Fertil Steril 1986;45:63–68
Dulgi AM, Laufer N, Decherney AH, Maclusky NJ, Haseltine FP, Dolan ML, Mezer HC, Tarlatzis B, Naftolin F: The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. Fertil Steril 1984;41:530–537
Hackeloer BJ, Fleming R, Robinson HP: Correlation of ultrasonic and endocrinologic assessment of human follicular development. Am J Obstet Gynecol 1979;135:122–128
Forman R, Fries N, Testart J, Belaisch-Allart J, Harout A, Frydman R: Evidence for an adverse effect of elevated serum estradiol concentration on embryo implantation. Fertil Steril 1988;49:118–122
Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S: Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high and poor responders to hMG. J Vitro Fert Embryo Trans 1991;8:33–36
Leyendecker G, Bernart W, Bremen TN, Beck H, Kunz G, Waibel S, Blum A, Stenger P, Kaplan-Reiterer H: Influence of the duration of the oestradiol rise on the success rate in GnRH analogue/hMG-stimulated IVF cycles. Hum Reprod 1990;5:52–55
Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N, Frydman R: Embryo quality and uterine receptivity in in vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. Hum Reprod 1989;4:198–201
Pellicer A, Ruiz A, Castellvi RM, Calatayud C, Ruiz M, Tarin JJ, Miro F, Bonilla-Musoles F: Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotropin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod 1989;4:536–540
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dor, J., Seidman, D.S., Ben-Shlomo, I. et al. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 9, 228–232 (1992). https://doi.org/10.1007/BF01203818
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01203818